Literature DB >> 9688629

Stimulatory effect of lithium on glucose transport in rat adipocytes is not mediated by elevation of IP1.

X Chen1, E G McMahon, E A Gulve.   

Abstract

Lithium has been shown to increase glucose uptake in skeletal muscle and adipose tissues. The therapeutic effect of lithium on bipolar disease is thought to be mediated by its inhibitory effect on myo-inositol-1-monophosphatase (IMPase). We tested the hypothesis that the stimulatory effect of lithium on glucose uptake results from inhibition of IMPase and the resultant accumulation of inositol monophosphates (IP1) by comparing the effects of lithium and a selective IMPase inhibitor, L-690,488, on isolated rat adipocytes. Insulin produced a concentration-dependent stimulation of 2-deoxy-D-[14C]glucose (2-DG) transport (10 microU/ml caused half-maximal activation). Acute exposure to lithium stimulated basal glucose transport activity in a concentration-dependent manner, with a threefold stimulation at 30 mM lithium. Lithium also potentiated insulin-stimulated 2-DG transport. Lithium produced a concomitant increase in IP1 accumulation. In contrast, L-690,488 increased IP1 to levels comparable to those of lithium without stimulatory effects on 2-DG transport. These results demonstrate that stimulatory effects of lithium on glucose transport are not mediated by the inhibition of IMPase and subsequent accumulation of IP1 in rat adipocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688629     DOI: 10.1152/ajpendo.1998.275.2.E272

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

Review 1.  GSK3 takes centre stage more than 20 years after its discovery.

Authors:  S Frame; P Cohen
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

2.  Stable isotope-resolved metabolomic analysis of lithium effects on glial-neuronal metabolism and interactions.

Authors:  Teresa W-M Fan; Peixiong Yuan; Andrew N Lane; Richard M Higashi; Yun Wang; Anahita B Hamidi; Rulun Zhou; Xavier Guitart; Guang Chen; Husseini K Manji; Rima Kaddurah-Daouk
Journal:  Metabolomics       Date:  2010-06-01       Impact factor: 4.290

3.  The association between leptin and adiponectin, and metabolic syndrome components and serum levels of lipid peroxidation in bipolar disorder patients treated with lithium and valproic acid.

Authors:  Neda Dolab; Mohammad Zaman Kamkar; Taghi Amiriani; Jale Yuzugulen; Majid Marjani; Abdoljalal Marjani
Journal:  Heliyon       Date:  2020-07-27

4.  Shilianhua extract inhibits GSK-3beta and promotes glucose metabolism.

Authors:  Jun Yin; Aamir Zuberi; Zhanguo Gao; Dong Liu; Zhijun Liu; Jianping Ye
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-04-07       Impact factor: 4.310

Review 5.  Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden.

Authors:  Andrea Fagiolini; K N Roy Chengappa; Isabella Soreca; Jane Chang
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Glycogen synthase kinase-3 regulates IGFBP-1 gene transcription through the thymine-rich insulin response element.

Authors:  David Finlay; Satish Patel; Lorna M Dickson; Natalia Shpiro; Rodolfo Marquez; Chris J Rhodes; Calum Sutherland
Journal:  BMC Mol Biol       Date:  2004-09-06       Impact factor: 2.946

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.